stockrow
Friday 6 November 2026
Export YCBD’s income statement to Excel — free account
cbdMD, Inc.
YCBD Healthcare Drug Manufacturers Specialty & Generic
cbdMD, Inc.’s revenue for fiscal 2025 (year ended September 2025) was $19.2 million, down 1.50% from fiscal 2024.
- Revenue
- +20.6%
- EPS
- +47.6%
- Free cash flow
- +34.8%
Quarter to June 2026, against a year earlier
0.40
0.01
+2.56%
Follow YCBD
Alert me
| Sep '25 | Sep '24 | Sep '23 | Sep '22 | Sep '21 | Sep '20 | Sep '19 | Sep '18 | Sep '17 | Sep '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
6 | 4 | 3 | 2 | 4 | 3 | 2 | 4 | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.77 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
(21.65) | (23.39) | (17.74) | (9.35) | 2.45 | 1.10 | (0.25) | 16.76 | — | — |
P/S ratio |
0.56 | 0.19 | 0.09 | 0.38 | 2.57 | 2.11 | 2.99 | 101.00 | 5.60 | 5.60 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(53.04) | (59.34) | (41.73) | (19.43) | 3.57 | 1.11 | (1.58) | 17.22 | 1.72 | (28.46) |
Beneish M-Score |
(2.51) | (4.79) | (8.40) | (8.93) | (3.00) | (1.79) | 41.82 | 26.13 | 1.13 | — |
P/Operating CF |
(45.02) | 21.72 | (7.98) | (6.99) | (26.35) | (227.81) | (11.19) | (63.28) | (27.89) | (27.89) |
P/B ratio |
1.50 | 1.86 | 0.23 | 0.43 | 1.11 | 1.11 | 1.88 | 3.31 | 4.89 | 4.89 |
Price to Tangible BV |
2.13 | 0.00 | 0.36 | 0.99 | 4.87 | 30.66 | 0.00 | 4.28 | 13.19 | 13.19 |
EV/Sales |
0.57 | 0.18 | 0.06 | 0.19 | 1.98 | 1.79 | 2.81 | 88.59 | 5.60 | 5.60 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 172.26 | 172.26 |
EV/Operating CF |
(7.56) | (10.17) | (0.31) | (0.46) | (6.24) | (7.02) | (4.32) | (7.30) | (10.86) | (10.86) |
EV/FCF |
(6.44) | (5.86) | (0.29) | (0.44) | (6.07) | (6.22) | (3.99) | (6.83) | (10.82) | (10.82) |
Quick Ratio |
1.03 | 0.40 | 0.65 | 1.73 | 4.13 | 2.14 | 2.20 | 10.39 | 1.47 | 0.10 |
Current Ratio |
2.05 | 0.74 | 1.73 | 3.03 | 5.28 | 3.08 | 4.24 | 12.15 | 2.42 | 0.50 |
Net Debt/EBITDA |
6.17 | 1.64 | 0.28 | 0.57 | 1.66 | 0.85 | 0.36 | 4.86 | (5.69) | (0.21) |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.31% | 0.09% | 1.55% | 0.39% | 0.05% | 5.09% | 49.13% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.01 | 0.00 | 0.07 | (2.72) |
Asset Turnover |
1.83 | 1.46 | 0.85 | 0.43 | 0.38 | 0.41 | 0.43 | 0.04 | 1.03 | 0.47 |
Operating CF/Net income |
0.33 | 0.05 | 0.16 | 0.20 | 0.54 | (0.87) | 0.30 | 13.52 | 1.34 | 0.86 |
Capex/Depreciation |
(0.10) | (0.16) | (0.02) | (0.01) | (0.11) | (0.69) | (1.72) | (0.83) | (0.02) | (1.44) |
Interest Coverage |
— | — | (353.02) | (4,831.27) | (678.75) | 440.65 | (197.03) | (1,797.10) | (0.48) | (24.09) |
| (95.30%) | (140.27%) | (133.22%) | (110.12%) | (28.47%) | 20.95% | (195.37%) | (4.30%) | (71.61%) | (171.28%) | |
| (41.67%) | (57.54%) | (94.55%) | (89.43%) | (22.02%) | 11.92% | (92.08%) | (3.73%) | (40.00%) | (77.22%) | |
ROIC |
(27.22%) | 0.00% | (194.30%) | (205.28%) | (16.17%) | (16.70%) | (28.48%) | (14.91%) | (3.43%) | (495.92%) |
Return on Tangible Assets |
(120.37%) | 434.13% | (654.48%) | (641.47%) | (80.72%) | 63.70% | (366.79%) | (3.79%) | (75.41%) | 437.33% |
Average Days of Receivables |
19.80 | 18.43 | 18.38 | 14.94 | 9.23 | 11.84 | 41.14 | 2,853.85 | 89.93 | 29.46 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.20 | 0.27 | 0.20 | 0.44 | 0.64 | 0.69 | 0.81 | 0.21 | 0.46 | 0.30 |
Share Based Compensation of Revenue |
0.45% | 0.03% | 0.97% | 1.57% | 3.14% | 5.34% | 11.62% | 247.46% | 15.67% | 11.64% |
Graham Net Nets |
0.31 | (0.61) | 0.43 | 0.49 | 0.13 | (0.09) | (0.58) | 0.23 | 0.07 | 0.07 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1,666.64 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(326.11%) | (493.48%) | (1,496.50%) | (555.84%) | (21.17%) | 26.52% | (66.72%) | (1.55%) | (5.52%) | (5.52%) |
Free Cash Flow Yield |
(15.74%) | (16.85%) | (221.06%) | (116.75%) | (12.68%) | (13.64%) | (23.51%) | (12.85%) | (9.25%) | (9.25%) |
Revenue per Share |
4.77 | 36.14 | 95.55 | 213.27 | 291.68 | 341.91 | 476.85 | 21.35 | 355.16 | 244.77 |
Operating CF per Share |
(0.36) | (0.65) | (17.02) | (90.16) | (92.42) | (87.06) | (310.03) | (259.21) | (184.90) | (349.07) |
Capex per Share |
(0.05) | (0.54) | (1.18) | (4.15) | (2.24) | (10.78) | (25.17) | (17.84) | (0.63) | (15.34) |
Free Cash Flow per Share |
(0.41) | (1.19) | (18.19) | (94.31) | (94.66) | (97.83) | (335.20) | (277.06) | (185.54) | (364.41) |
Cash per Share |
0.56 | 4.55 | 7.11 | 46.51 | 179.97 | 123.27 | 110.79 | 301.98 | 90.75 | 4.13 |
Shareholders Equity per Share |
1.80 | 3.64 | 35.73 | 189.30 | 676.34 | 646.38 | 758.15 | 652.06 | 408.64 | (35.27) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
1.80 | 3.64 | 35.73 | 189.30 | 676.34 | 646.38 | 758.15 | 652.06 | 408.64 | (35.27) |
Free Cash Flow |
(1.64) | (0.64) | (4.60) | (15.66) | (14.44) | (11.98) | (16.63) | (5.96) | (2.34) | (3.02) |
Working Capital |
3.36 | (2.23) | 3.40 | 10.73 | 29.59 | 16.02 | 12.03 | 10.82 | 2.17 | (0.95) |
Capital Expenditures |
(0.18) | (0.29) | (0.30) | (0.69) | (0.34) | (1.32) | (1.25) | (0.38) | (0.01) | (0.13) |
Net Current Asset Value |
3.36 | (2.23) | 0.91 | 6.64 | 14.76 | (7.95) | (41.17) | 10.79 | 1.77 | (0.96) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.02 | 0.01 | 0.03 | 0.05 | 0.84 | 0.00 | 0.06 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
6.47 | 4.01 | 22.53 | 78.75 | 1.22 | 0.60 | 0.42 | 8.64 | 2.78 | 0.49 |
Cash ROIC |
(17.25%) | (14.56%) | (42.47%) | (39.87%) | (11.05%) | (12.48%) | (38.25%) | (29.03%) | (35.14%) | (561.05%) |
Accounts Receivable Turnover |
18.96 | 17.71 | 18.13 | 27.51 | 35.83 | 20.81 | 7.56 | 0.20 | 7.07 | 2.63 |
Accounts Payable Turnover |
5.32 | 4.34 | 4.66 | 5.21 | 4.97 | 5.28 | 5.22 | 0.22 | 4.04 | 4.82 |
Inventory Turnover |
2.83 | 2.33 | 2.21 | 2.82 | 3.01 | 3.48 | 4.13 | 0.29 | 2.25 | 2.69 |
Average Days of Payables |
59.31 | 75.13 | 75.81 | 56.89 | 75.01 | 67.06 | 120.70 | 1,690.23 | 125.36 | 46.50 |
Days of Inventory on Hand |
138.08 | 115.31 | 161.19 | 118.88 | 126.46 | 108.30 | 171.84 | 432.38 | 158.40 | 138.52 |
Average Receivables |
1.01 | 1.10 | 1.33 | 1.29 | 1.24 | 2.01 | 3.13 | 2.35 | 0.63 | 0.77 |
Average Payables |
1.36 | 1.72 | 1.97 | 2.51 | 2.91 | 2.94 | 1.75 | 0.47 | 0.34 | 0.34 |
Average Inventory |
2.55 | 3.21 | 4.15 | 4.64 | 4.81 | 4.45 | 2.21 | 0.36 | 0.60 | 0.60 |
Average Assets |
10.50 | 13.39 | 28.49 | 82.84 | 117.86 | 102.68 | 54.77 | 11.04 | 4.35 | 4.35 |
Average Common Equity |
4.59 | 5.49 | 20.22 | 67.28 | 91.16 | 58.39 | 25.81 | 9.58 | 2.43 | 1.96 |
Columns are period end dates · fundamentals updated 26 Oct 2026